Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-29 Sale | 2022-07-01 6:00 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 25,000 | $61.59 | $1,539,862 | 298,612 (Direct) | View |
| 2021-08-06 Sale | 2021-08-10 8:00 pm | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 25,000 | $138.52 | $3,462,926 | 132,891 (Direct) | View |
| 2021-08-04 Sale | 2021-08-06 8:00 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 30,000 | $128.78 | $3,863,469 | 282,885 (Direct) | View |
| 2021-07-19 Sale | 2021-07-21 5:21 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) | View |
| 2021-06-30 Sale | 2021-07-01 5:43 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 25,000 | $165 | $4,125,000 | 573,007 (Direct) | View |
| 2021-06-28 Sale | 2021-06-30 6:41 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-29 Exercise | 2022-07-01 6:00 pm | N/A 2026-07-15 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 25,000 | $0 | 298,612 (Direct) | View |
| 2022-06-29 Exercise | 2022-07-01 6:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 25,000 | $12.57 | 298,612 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:46 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:44 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:43 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:41 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Greene John Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:39 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:37 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Fardis Maria Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:36 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:35 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-24 5:55 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer | 117,750 | $0 | 117,750 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-14 6:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,834 | $0 | 329,112 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 4,153 | $61.08 | 329,112 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 5,487 | $62.56 | 329,112 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 7,584 | $0 | 40,380 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 1,229 | $61.08 | 40,380 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 1,883 | $62.56 | 40,380 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-14 6:01 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 5,084 | $0 | 56,012 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:01 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,039 | $61.08 | 56,012 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 6:01 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,321 | $62.56 | 56,012 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:44 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | Smith Brendan CFO | 45,300 | $0 | 45,300 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:43 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 168,000 | $0 | 168,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:41 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 66,600 | $0 | 66,600 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:40 pm | N/A 2032-02-18 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 49,500 | $0 | 49,500 (Direct) | View |
| 2021-12-20 Exercise | 2021-12-22 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 17,750 | $1.81 | 337,318 (Direct) | View |
| 2021-12-20 Exercise | 2021-12-22 8:00 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 17,750 | $0 | 337,318 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 37,818 | $69.17 | 301,335 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 80,000 | $0 | 301,335 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 11,185 | $69.17 | 35,658 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 26,667 | $0 | 35,658 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 12,607 | $69.17 | 65,697 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 26,667 | $0 | 65,697 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 6,303 | $69.17 | 50,209 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-07 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 13,333 | $0 | 50,209 (Direct) | View |
| 2021-12-02 Exercise | 2021-12-03 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 7,342 | $13.62 | 130,144 (Direct) | View |
| 2021-12-02 Exercise | 2021-12-03 8:00 pm | N/A 2027-05-31 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 7,342 | $0 | 130,144 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 779 | $75.1 | 219,153 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-18 8:00 pm | N/A 2031-10-15 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 10,800 | $0 | 10,800 (Direct) | View |
| 2021-10-14 Option Award | 2021-10-18 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan CFO | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-18 8:00 pm | N/A 2031-10-15 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 13,800 | $0 | 13,800 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-18 8:00 pm | N/A 2031-10-15 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 43,000 | $0 | 338,915 (Direct) | View |
| 2021-10-15 Exercise | 2021-10-18 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 33,000 | $1.81 | 338,915 (Direct) | View |
| 2021-10-15 Exercise | 2021-10-18 8:00 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 33,000 | $0 | 338,915 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-18 8:00 pm | N/A 2031-10-15 | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 13,800 | $0 | 13,800 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 4,741 | $117.86 | 29,170 (Direct) | View |
| 2021-09-10 Disposition | 2021-09-14 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 10,000 | $0 | 29,170 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-14 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 10,000 | $0 | 29,170 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,207 | $117.86 | 6,843 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 6,843 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 6,843 (Direct) | View |
| 2021-09-01 Tax Withholding | 2021-09-03 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 787 | $124.83 | 186,932 (Direct) | View |
| 2021-08-06 Exercise | 2021-08-10 8:00 pm | N/A 2027-11-21 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 25,000 | $0 | 132,891 (Direct) | View |
| 2021-08-06 Exercise | 2021-08-10 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 25,000 | $17.75 | 132,891 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 8:00 pm | N/A 2026-07-15 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 30,000 | $0 | 282,885 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 30,000 | $12.57 | 282,885 (Direct) | View |
| 2021-06-28 Other | 2021-06-30 6:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,416,648 | $0 | 1,581,188 (Indirect) | View |